RNS Number : 0533R
Georgia Healthcare Group PLC
25 February 2019
London, 25 February 2019
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
|
1.
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Giorgi Mindiashvili
|
|
2.
|
Reason for the notification
|
|
a)
|
Position / status
|
PDMR, Deputy CEO
|
|
b)
|
Initial notification / amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Georgia Healthcare Group PLC
|
|
b)
|
LEI:
|
213800RJGJDDZENQER80
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification Code
|
ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
|
b)
|
Nature of the transaction
|
Exercise of nil-cost options over GHG ordinary shares pursuant to the employee share option programme
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
nil
|
86,609
|
|
|
d)
|
Aggregated information
|
|
|
|
Aggregated volume
|
Please note that a total of 17,322 shares were withheld to meet tax liabilities, resulting in the receipt of 69,287 shares.
|
|
|
Aggregated price
|
nil
|
|
|
|
|
|
e)
|
Date of the transactions
|
20 February 2019
|
|
f)
|
Place of the transaction
|
Outside of a trading venue
|
Name of authorised official of issuer responsible for making notification:
Link Company Matters Limited, Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the
United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHLLFFEFEIEFIA